These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 15623375

  • 1. [The relationship of serum metalloproteinase with the severity of liver fibrosis and inflammation].
    Yin SS, Li XM, Wang BE, Wang TL, Jia JD, Qian LX.
    Zhonghua Gan Zang Bing Za Zhi; 2004 Nov; 12(11):666-8. PubMed ID: 15623375
    [Abstract] [Full Text] [Related]

  • 2. [The effect of Cpd 861 on chronic hepatitis B related fibrosis and early cirrhosis: a randomized, double blind, placebo controlled clinical trial].
    Yin SS, Wang BE, Wang TL, Jia JD, Qian LX.
    Zhonghua Gan Zang Bing Za Zhi; 2004 Aug; 12(8):467-70. PubMed ID: 15329205
    [Abstract] [Full Text] [Related]

  • 3. Value of fibrosis markers for staging liver fibrosis in patients with precirrhotic alcoholic liver disease.
    Lieber CS, Weiss DG, Paronetto F, Veterans Affairs Cooperative Study 391 Group.
    Alcohol Clin Exp Res; 2008 Jun; 32(6):1031-9. PubMed ID: 18422837
    [Abstract] [Full Text] [Related]

  • 4. Serum levels of tissue inhibitor of metalloproteinase-1 are correlated with liver fibrosis in patients with chronic hepatitis B.
    Zhu CL, Li WT, Li Y, Gao RT.
    J Dig Dis; 2012 Nov; 13(11):558-63. PubMed ID: 23107442
    [Abstract] [Full Text] [Related]

  • 5. Longitudinal evaluation of a fibrosis index combining MMP-1 and PIIINP compared with MMP-9, TIMP-1 and hyaluronic acid in patients with chronic hepatitis C treated by interferon-alpha and ribavirin.
    Trocme C, Leroy V, Sturm N, Hilleret MN, Bottari S, Morel F, Zarski JP.
    J Viral Hepat; 2006 Oct; 13(10):643-51. PubMed ID: 16970595
    [Abstract] [Full Text] [Related]

  • 6. [A quantitative study of the relationship between levels of liver fibrosis markers in sera and fibrosis stages of liver tissues of patients with chronic hepatic diseases].
    Ding XJ, Li SB, Li SZ, Liu HS, Liu B, Xu FM, Gu RW.
    Zhonghua Gan Zang Bing Za Zhi; 2005 Dec; 13(12):911-4. PubMed ID: 16381637
    [Abstract] [Full Text] [Related]

  • 7. [The diagnostic value of serum hyaluronic acid, 7S domain of type IV collagen and AST/ALT ratio as markers of hepatic fibrosis in chronic hepatitis B and cirrhosis patients].
    Park JH, Park CK, Kim ES, Park SY, Jo CM, Tak WY, Kweon YO, Kim SK, Choi YW.
    Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):79-88. PubMed ID: 12824747
    [Abstract] [Full Text] [Related]

  • 8. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis.
    Parés A, Deulofeu R, Giménez A, Caballería L, Bruguera M, Caballería J, Ballesta AM, Rodés J.
    Hepatology; 1996 Dec; 24(6):1399-403. PubMed ID: 8938169
    [Abstract] [Full Text] [Related]

  • 9. Replacement of hystological findings: serum hyaluronic acid for fibrosis, high-sensitive C-reactive protein for necroinflamation in chronic viral hepatitis.
    Yilmaz S, Bayan K, Tüzün Y, Dursun M, Kaplan A, Ozmen S, Canoruç F, Akkuş Z.
    Int J Clin Pract; 2007 Mar; 61(3):438-43. PubMed ID: 17313611
    [Abstract] [Full Text] [Related]

  • 10. Serum hyaluronic acid and laminin as biomarkers in liver fibrosis.
    Parsian H, Rahimipour A, Nouri M, Somi MH, Qujeq D, Fard MK, Agcheli K.
    J Gastrointestin Liver Dis; 2010 Jun; 19(2):169-74. PubMed ID: 20593050
    [Abstract] [Full Text] [Related]

  • 11. Serum levels of hyaluronic acid and tissue metalloproteinase inhibitor-1 combined with age predict the presence of nonalcoholic steatohepatitis in a pilot cohort of subjects with nonalcoholic fatty liver disease.
    Miele L, Forgione A, La Torre G, Vero V, Cefalo C, Racco S, Vellone VG, Vecchio FM, Gasbarrini G, Rapaccini GL, Neuman MG, Grieco A.
    Transl Res; 2009 Oct; 154(4):194-201. PubMed ID: 19766963
    [Abstract] [Full Text] [Related]

  • 12. Plasma tissue inhibitor of metalloproteinases-1 and transforming growth factor beta 1--possible non-invasive biomarkers of hepatic fibrosis in patients with chronic B and C hepatitis.
    Flisiak R, Maxwell P, Prokopowicz D, Timms PM, Panasiuk A.
    Hepatogastroenterology; 2002 Oct; 49(47):1369-72. PubMed ID: 12239944
    [Abstract] [Full Text] [Related]

  • 13. [Biochemical markers of fibrosis in chronic hepatitis and liver cirrhosis of viral origin].
    Kozłowska J, Łoch T, Jabłońska J, Cianciara J.
    Przegl Epidemiol; 2001 Oct; 55(4):451-8. PubMed ID: 11921731
    [Abstract] [Full Text] [Related]

  • 14. Diagnostic value of platelet derived growth factor-BB, transforming growth factor-beta1, matrix metalloproteinase-1, and tissue inhibitor of matrix metalloproteinase-1 in serum and peripheral blood mononuclear cells for hepatic fibrosis.
    Zhang BB, Cai WM, Weng HL, Hu ZR, Lu J, Zheng M, Liu RH.
    World J Gastroenterol; 2003 Nov; 9(11):2490-6. PubMed ID: 14606082
    [Abstract] [Full Text] [Related]

  • 15. [Diagnostic value of five serum markers for liver fibrosis].
    Luo R, Yang S, Xie J, Zhao Z, He Y, Yao J.
    Zhonghua Gan Zang Bing Za Zhi; 2001 Jun; 9(3):148-50. PubMed ID: 11412388
    [Abstract] [Full Text] [Related]

  • 16. [Relationship between serum HBV DNA levels and hepatic fibrosis markers in chronic hepatitis B].
    Dong Z, Shen H, Zhang FK.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Jun; 21(2):129-31. PubMed ID: 17653313
    [Abstract] [Full Text] [Related]

  • 17. [Screening and evaluation of non-invasive diagnosis markers for compensated liver cirrhosis in patients with chronic hepatitis B].
    Chen YP, Feng XR, Dai L, Ding HB, Zhang L.
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):225-7. PubMed ID: 12716522
    [Abstract] [Full Text] [Related]

  • 18. Altered pattern of circulating matrix metalloproteinases -2,- 9 and tissue inhibitor of metalloproteinase-2 in patients with HCV-related chronic hepatitis. Relationship to histological features.
    Bruno CM, Valenti M, Bertino G, Ardiri A, Consolo M, Mazzarino CM, Amoroso A, Neri S.
    Panminerva Med; 2009 Dec; 51(4):191-6. PubMed ID: 20195229
    [Abstract] [Full Text] [Related]

  • 19. [Correlation between liver fibrosis stage and serum liver fibrosis markers in patients with chronic hepatitis B].
    Ding H, Chen Y, Feng X, Liu D, Wu A, Zhang L.
    Zhonghua Gan Zang Bing Za Zhi; 2001 Apr; 9(2):78-80. PubMed ID: 11350682
    [Abstract] [Full Text] [Related]

  • 20. Assessment of FIBROSpect II to detect hepatic fibrosis in chronic hepatitis C patients.
    Zaman A, Rosen HR, Ingram K, Corless CL, Oh E, Smith K.
    Am J Med; 2007 Mar; 120(3):280.e9-14. PubMed ID: 17349453
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.